Balboa Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.57M Buy
10,494
+204
+2% +$47.5K 0.43% 40
2025
Q4
$2.13M Buy
10,290
+1,780
+21% +$352K 0.35% 51
2025
Q3
$1.58M Buy
8,510
+166
+2% +$28.4K 0.27% 61
2025
Q2
$1.27M Buy
8,344
+882
+12% +$136K 0.26% 71
2025
Q1
$1.24M Sell
7,462
-249
-3% -$39K 0.3% 62
2024
Q4
$1.12M Buy
7,711
+162
+2% +$25.1K 0.25% 70
2024
Q3
$1.22M Buy
7,549
+267
+4% +$42.5K 0.3% 64
2024
Q2
$1.06M Buy
7,282
+1,023
+16% +$152K 0.28% 67
2024
Q1
$990K Buy
6,259
+48
+0.8% +$7.64K 0.29% 65
2023
Q4
$974K Sell
6,211
-473
-7% -$72.5K 0.32% 61
2023
Q3
$1.04M Buy
6,684
+26
+0.4% +$4.29K 0.39% 39
2023
Q2
$1.1M Sell
6,658
-940
-12% -$152K 0.38% 41
2023
Q1
$1.18M Buy
7,598
+388
+5% +$62.7K 0.44% 41
2022
Q4
$1.27M Sell
7,210
-343
-5% -$59.2K 0.57% 36
2022
Q3
$1.23M Buy
+7,553
New +$1.28M 0.54% 36

Other funds holding JNJ

Balboa Wealth Partners's JNJ Position: Q1 2026 in Review

Balboa Wealth Partners increased its Johnson & Johnson (JNJ) stake by 2% in Q1 2026, buying an estimated $47.5K and bringing the position to 10,494 shares worth $2.57M. The position accounts for 0.43% of the portfolio, ranked #40.

Balboa Wealth Partners first reported a position in JNJ in Q3 2022 and has held it in 15 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Balboa Wealth Partners held 10,494 shares of Johnson & Johnson worth $2.57M as of Q1 2026.
  • Balboa Wealth Partners bought 204 Johnson & Johnson shares in Q1 2026, an estimated $47.5K.
  • Johnson & Johnson made up 0.43% of Balboa Wealth Partners's portfolio in Q1 2026, its #40 holding.
  • Balboa Wealth Partners first reported a position in Johnson & Johnson in Q3 2022 and has held it in 15 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Balboa Wealth Partners's 13F filing for Q1 2026, filed 16 Apr 2026.